Are you Dr. Frew?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1230 York Ave
New York, NY 10065Phone+1 212-327-7153Fax+1 212-327-8232- Is this information wrong?
Summary
- Dr. John Frew, MD is a dermatologist in New York, New York. He is currently licensed to practice medicine in New York.
Education & Training
- University of New South Wales Faculty of MedicineClass of 2009
Certifications & Licensure
- NY State Medical License 2019 - 2022
Clinical Trials
- Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab Start of enrollment: 2019 May 28
- Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab. Start of enrollment: 2020 Jun 01
- An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab Start of enrollment: 2020 Feb 03
Publications & Presentations
PubMed
- 20 citationsInterleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.Kristina Navrazhina, John W Frew, David Grand, Samuel C Williams, Hong Hur, Juana Gonzalez, Sandra Garcet, James G Krueger> ;The British Journal of Dermatology. 2022 Aug 1
- 6 citationsClinical Considerations in the Management of Hidradenitis Suppurativa in WomenEmily K. Kozera, Michelle A. Lowes, Jennifer L. Hsiao, John W. Frew> ;International Journal of Women's Dermatology. 2021 Oct 29
- 2 citationsAutoantibody-Mediated Macrophage Responses Provide the Missing Link between Innate and Adaptive Immune Dysfunction in Hidradenitis SuppurativaJohn W. Frew> ;The Journal of Investigative Dermatology. 2021 Oct 26
- Join now to see all
Press Mentions
- Is a Vaccine for Melanoma on the Cards?December 14th, 2022
- Aussie HS Patients Show Good Responses to JAK Inhibitor TherapyAugust 9th, 2022
- The Fallout When Dermatologists and Patients Don’t AgreeAugust 20th, 2023